Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
escapar 4.6 mg/24 h cerotto transdermico
acino pharma ag - rivastigminum - cerotto transdermico - rivastigminum 6,9 mg, excipiens per la preparazione per il 4.6 cm2 con la liberazione di 4,6 mg/24 ore. - demenza di tipo alzheimer - sintetica umana
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
escapar 9.5 mg/24 h cerotto transdermico
acino pharma ag - rivastigminum - cerotto transdermico - rivastigminum di 13,8 mg, excipiens per la preparazione per la 9.2 cm2 con la liberazione di 9,5 mg/24 ore. - demenza di tipo alzheimer - sintetica umana
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
exelon
bb farma s.r.l. - rivastigmina - rivastigmina
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
rivirec
italfarmaco s.p.a. - rivastigmina - rivastigmina
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivasur zweimal wöchentlich 4,6 mg/24 stunden cerotto transdermico
luye pharma switzerland ag - rivastigminum - cerotto transdermico - i) (transdermales pflaster): rivastigminum 25.92 mg, e 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, trägermaterial: poly(ethylenis terephthalas), polyethylenum, drucktinte: blau, ad praeparationem pro 10.8 cm², cum liberatione 4.6 mg/24h. ii) (abdeckpfaster): acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ad praeparationem pro 25.1 cm². - demenza di tipo alzheimer - synthetika
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivasur zweimal wöchentlich 9,5 mg/24 stunden cerotto transdermico
luye pharma switzerland ag - rivastigminum - cerotto transdermico - i) (transdermales pflaster): rivastigminum 51.84 mg, e 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, trägermaterial: poly(ethylenis terephthalas), polyethylenum, drucktinte: blau, ad praeparationem pro 21.6 cm², cum liberatione 9.5 mg/24h. ii) (abdeckpflaster): acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ad praeparationem pro 46.7 cm². - demenza di tipo alzheimer - synthetika
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-acino 4.6 mg/24 h transdermales pflaster
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-acino 4.6 mg/24 h dispositif transdermique
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-acino 9.5 mg/24 h transdermales pflaster
Šveice -
itāļu -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-acino 9.5 mg/24 h dispositif transdermique